| Literature DB >> 34216541 |
Priya Ranganathan1, Girish Chinnaswamy2, Manju Sengar3, Durga Gadgil4, Shivakumar Thiagarajan5, Balram Bhargava6, Christopher M Booth7, Marc Buyse8, Sanjiv Chopra9, Chris Frampton10, Satish Gopal11, Nick Grant12, Mark Krailo13, Ruth Langley14, Prashant Mathur15, Xavier Paoletti16, Mahesh Parmar14, Arnie Purushotham17, Douglas Pyle18, Preetha Rajaraman19, Martin R Stockler20, Richard Sullivan21, Soumya Swaminathan22, Ian Tannock23, Edward Trimble24, Rajendra A Badwe25, C S Pramesh25.
Abstract
Low-income and middle-income countries (LMICs) have a disproportionately high burden of cancer and cancer mortality. The unique barriers to optimum cancer care in these regions necessitate context-specific research. The conduct of research in LMICs has several challenges, not least of which is a paucity of formal training in research methods. Building capacity by training early career researchers is essential to improve research output and cancer outcomes in LMICs. The International Collaboration for Research methods Development in Oncology (CReDO) workshop is an initiative by the Tata Memorial Centre and the National Cancer Grid of India to address gaps in research training and increase capacity in oncology research. Since 2015, there have been five CReDO workshops, which have trained more than 250 oncologists from India and other countries in clinical research methods and protocol development. Participants from all oncology and allied fields were represented at these workshops. Protocols developed included clinical trials, comparative effectiveness studies, health services research, and observational studies, and many of these protocols were particularly relevant to cancer management in LMICs. A follow-up of these participants in 2020 elicited an 88% response rate and showed that 42% of participants had made progress with their CReDO protocols, and 73% had initiated other research protocols and published papers. In this Policy Review, we describe the challenges to research in LMICs, as well as the evolution, structure, and impact of CReDO and other similar workshops on global oncology research.Entities:
Mesh:
Year: 2021 PMID: 34216541 PMCID: PMC8328959 DOI: 10.1016/S1470-2045(21)00077-2
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 54.433